One-Stop In Vitro Diagnostics (IVD) CDMO Partner | From Lab to Market
Expert Call: (86) 23-86916205
Submit Project Inquiry

IVDCDMO Team

Home
Author: IVDCDMO Team
Page 2
CDMO Custom Development of Test Kits: From Assay Concept to Scalable IVD Manufacturing
23Sep 2026
Assay Development, IVD Manufacturing IVDCDMO Team Comments: 0

CDMO Custom Development of Test Kits: From Assay Concept to Scalable IVD Manufacturing

CDMO custom development of test kits provides diagnostic companies with a structured route from an initial assay concept to a reproducible, manufacturable and commercially viable in vitro diagnostic product. Instead of outsourcing only one isolated development task, an IVD-focused CDMO program can integrate assay design, raw-material selection, reagent formulation, analytical optimization, pilot production, stability studies, manufacturing transfer and regulatory-support documentation into a coo...
Read More
Manufacturing for IVD Products: From Assay Transfer to Reliable Commercial Supply
24Jul 2026
IVD Manufacturing IVDCDMO Team Comments: 0

Manufacturing for IVD Products: From Assay Transfer to Reliable Commercial Supply

A diagnostic assay can perform beautifully in the development laboratory and still fail as a commercial product. The reason is simple: an experiment is judged by whether it works today, in the hands of the development team. A manufactured IVD product must work across operators, equipment, raw-material lots, production sites, shipping routes and months of storage—without drifting beyond its validated performance claims. That is the real purpose of manufacturing for IVD products. It is not merel...
Read More
IVD Contract Manufacturing Cost: NRE, Tooling, Validation, MOQ and Unit Economics
13Jul 2026
IVD Manufacturing IVDCDMO Team Comments: 0

IVD Contract Manufacturing Cost: NRE, Tooling, Validation, MOQ and Unit Economics

An IVD contract manufacturing quote can appear competitive and still produce poor commercial economics. The quoted unit price often covers only the visible production work: reagents, components, assembly, packaging and routine labor. It may not show the substantial cost of assay transfer, manufacturing engineering, custom fixtures, process validation, lot-release testing, stability commitments, scrap, retained samples, inventory exposure or changes introduced after design freeze. A useful IVD co...
Read More
IVD CDMO vs CRO vs CMO
06Jul 2026
Knowledge IVDCDMO Team Comments: 0

IVD CDMO vs CRO vs CMO: Which Partner Do You Need at Each Development Stage?

The difference between an IVD CDMO, CRO and CMO is not simply the range of services listed on a supplier’s website. Each type of partner is designed to remove a different category of program risk. An IVD CDMO is most valuable when the product or manufacturing process is still being developed. A CRO becomes critical when the remaining uncertainty concerns specimens, study execution, clinical evidence or statistical validity. A CMO is usually the right choice when the design is sufficiently matu...
Read More
What Is the Meaning of IVD in Pharma?
23Jun 2026
Knowledge IVDCDMO Team Comments: 0

What Is the Meaning of IVD in Pharma? A Comprehensive Expert Guide

Understanding IVD in the Pharmaceutical and Healthcare Context In the pharmaceutical and healthcare industries, IVD stands for In Vitro Diagnostics. The term “in vitro” literally translates to “in glass,” referring to analytical tests performed outside a living human or animal organism. Unlike therapeutic drugs that directly intervene in bodily biological systems to cure, relieve or prevent disease, IVD products analyze patient biospecimens—including whole blood, plasma, serum, urine,...
Read More
What Is IVD Manufacturing? A Complete Guide to In Vitro Diagnostic Manufacturing
21Jun 2026
IVD Manufacturing IVDCDMO Team Comments: 0

What Is IVD Manufacturing? A Complete Guide to In Vitro Diagnostic Manufacturing

Understanding IVD Manufacturing in Modern Global Healthcare In vitro diagnostic (IVD) manufacturing encapsulates the full spectrum of research, scaled production, performance verification and commercial rollout for diagnostic devices designed to analyze human biological samples outside a living body. Sample matrices processed within IVD facilities cover whole blood, serum, plasma, urine, oral fluid, tissue homogenates and other bio-specimens collected from patients for clinical testing. These di...
Read More
Why IVD CDMO Is Reshaping the Future of Diagnostic Product Commercialization
19Jun 2026
CDMO Insights, Industry News IVDCDMO Team Comments: 0

Why IVD CDMO Is Reshaping the Future of Diagnostic Product Commercialization

How End-to-End IVD CDMO Services Reduce Development Costs, Accelerate Regulatory Approval, and Improve Market Success The global in vitro diagnostics (IVD) industry is undergoing rapid transformation. As healthcare systems demand faster innovation, shorter development cycles, and stricter regulatory compliance, many diagnostic companies are rethinking how new products are brought to market. Traditionally, diagnostic manufacturers built their own research teams, established production facilities,...
Read More
IVD Product FDA Clearance Guide: A Comprehensive Expert Approach
17Jun 2026
FDA 510(k), Regulatory & Quality IVDCDMO Team Comments: 0

IVD Product FDA Clearance Guide: A Comprehensive Expert Approach

Achieving FDA clearance for an in-vitro diagnostic (IVD) product is a rigorous process that demands strategic planning, thorough understanding of regulatory requirements, and precise execution. For manufacturers, CDMOs, and startups entering the U.S. market, mastering the FDA clearance pathway is critical for market access, compliance, and patient safety. This guide delivers a practical, step-by-step roadmap to navigate FDA regulations, covering classification, pre-submission strategies, testing...
Read More
The Silicon Valley of Medical Hardware Decoding China’s Shenzhen Global Dominance in IVD CDMO Industrial Evolution
15Jun 2026
IVD Industry Insights IVDCDMO Team Comments: 0

China’s Silicon Valley of Medical Hardware: Decoding Shenzhen’s International Stature in IVD CDMO Industrial Evolution

The Tectonic Shift Reshaping the Global IVD Industry The global in vitro diagnostics (IVD) sector is undergoing a fundamental structural reshuffle, driven by overlapping macro and industrial forces. Worldwide healthcare systems are tightening medical reimbursement standards alongside DRG-based hospital cost containment frameworks, while China’s volume-based procurement (VBP) policy continues to compress gross profit margins for conventional diagnostic products. Concurrently, the industry is wi...
Read More
From $100 Million to $1,000 How Gene Sequencing Became Accessible to Everyone
12Jun 2026
News & Insights IVDCDMO Team Comments: 0

From $100 Million to $1,000: How Gene Sequencing Became Accessible to Everyone

The Extraordinary Journey of Gene Sequencing Technology In 2001, when the first draft of the human genome was unveiled, it marked one of the most significant scientific achievements in modern history. The international Human Genome Project spanned more than a decade, mobilized thousands of researchers worldwide, and posted an overall total investment exceeding $2.7 billion. Early commercial whole-human-genome sequencing based on first-generation Sanger chemistry carried a sticker price of roughl...
Read More